(R)-1-(5-Fluoro-2-methoxyphenyl)ethan-1-amine hydrochloride, 5g

(S)-N-(1-(Naphthalen-2-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine, 98%, 50mg

Methyl 2-(benzylamino)acetate, 95.0%, 100g

1-(4-Chloro-benzyl)-1 H -[1,2,4]triazol-3-ylamine, 5g

methyl 3-amino-1-(2,2-difluoroethyl)-1H-pyrazole-4-carboxylate, 10g

5-Chloro-6-methylpyrimidin-4-amine, 95.0%, 1g

4,4'-(Diazene-1,2-diyl)bis(4-cyanopentanoic acid) (contains 13-18% water), 99.0%, 100g

N-(8-Bromooctyl)phthalimide, 98.0%, 5g

3-allyl-6-(methylsulfonyl)benzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 1g

Lente Plan PLPHi S100x/1.25 contrasto di fase IOS corretta all'infinito

Nonanoic acid, 8-methyl-, (4-hydroxy-3-methoxyphenyl)methyl ester, 98%, 5mg

tert-Butyl 3-(cyanomethyl)-1H-indole-1-carboxylate, 95.0%, 100mg

2-(3-(Cyclopropylmethoxy)-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 1g